About US
Contact us
-
Titan's Probuphine could help FDA in its efforts to fight opioid abuseTheFDAis wrestling with a host of issues surrounding the highly addictive and often abusedopioidsand just recommended a drug that may provide some help in its effort. Yesterday an FDA advisory commit2013/3/25
-
New drug discovery company to focus on Alzheimer'sA new drug discovery company has been established to progress research into the development of new treatments for Alzheimer's disease. CoCo Therapeutics has been formed by King's College London, The2013/3/25
-
Novartis breast cancer drug Afinitor nixed by U.K. gatekeepersThe U.K.'s cost-effectiveness watchdog has turned awayAfinitorforbreast cancer. The Novartis ($NVS) drug doesn't offer enough value for the money, the National Institute for Health and Clinical Excel2013/3/22
-
Sanofi investors win class-action status in diet drug suitSanofi ($SNY)now faces an investor class action over its weight-loss drug Zimulti. And it may have Amgen ($AMGN) investors to thank. A few weeks after the U.S. Supreme Court cleared Amgen shareholder2013/3/22
-
Merck KGaA, Bristol-Myers plan joint assault on China's diabetes marketDiabetesis rampant inChina, and growing. And relatively few of the more than 90 million Chinese diabetics are treated. It's no wonder that pharma companies are piling into China, diabetes treatments2013/3/21
-
Sanofi manufacturing delays trigger TB drug shortageSanofi ($SNY) manufacturing delays have put itstuberculosisdrug Rifamate on the FDAshortagelist. The pill combines the antibiotic rifampin with isoniazid, a commonly used TB treatment that's been run2013/3/21
-
Senator questions Pfizer's $2,000-a-month price on XeljanzShould taxpayers enjoy lower drug prices if federal money backed development? At least one U.S. senator thinks so, now that Pfizer ($PFE) has slapped a $2,000-per-month sticker price on the newrheuma2013/3/20
-
Suit suggests Lilly warehouse burglars got hands on security assessmentThe daring heist of $70 million worth of drugs from an Eli Lilly ($LLY) warehouse two years ago rolled out like the script of a movie.The thieves hit a vulnerable spot on the roof, rapelled down rope2013/3/20
-
Novartis nabs EU clearance for Jetrea; Roche's hep C drug Pegasys wins new useNovartis ($NVS) won European approval for its eye drug Jetrea, as a treatment for vitreomacular traction, which can cause progressive and irreversible vision loss. The European Medicines Agency also a2013/3/19
-
National Essential Medicine List (2012 edition) releasedThe National Essential Medicine List (2012 edition) was recently released. The new list consists of three parts: chemical medicines and biological products, Chinese proprietary medicines, and prepare2013/3/19